ENT Department, Chania General Hospital, Chania, Crete, Greece.
ENT Department, John-Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Eur Ann Otorhinolaryngol Head Neck Dis. 2021 Oct;138(5):343-348. doi: 10.1016/j.anorl.2020.06.028. Epub 2021 Mar 3.
The present study aimed to investigate the effects of oral steroids on olfactory disturbances in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
This is a prospective randomized non-blinded study. Selected CRSwNP patients (n=140), with hyposmia, were devided into two groups; group A received a 7-day course of oral steroids with a 12-weeks course of nasal steroids and douching; group B received a 12-weeks course of nasal steroids and douching. Assessment included Sniffin' Sticks scores, visual analogue scale score for olfaction and discomfort (VASsmell, VASdis), the Sinonasal Outcome Test-22, Greek-version (SNOT22-Gr) and the endoscopic appearance (EAS).
The main objective was to compare the olfactory effect of the different therapy in group A and group B, at 2, 12 and 24 weeks. Accessory objectives included the comparison of EAS, VASdis and SNOT22-Gr between groups, the evaluation of the therapeutic outcome duration, and, the investigation of potential correlation between the evaluated parameters.
The 2-weeks evaluation showed a significant statistical difference (P<0.001) for all parameters except VASdis. Olfactory outcomes (Sniffin' Sticks and VASsmell scale scores) were found significantly better in group A at the 24-weeks evaluation (P<0.001). Within groups, the therapeutic result remained stable between the 12-weeks and 24-weeks evaluation (P>0.05). Sniffin' Sticks score was strongly correlated at 12-weeks evaluation with EAS (rho=0.58, P<0.001).
Our results suggest that a combination treatment of oral and nasal steroids in well-selected patients with CRSwNP may result in early olfaction restoration with a possible long-term effect.
本研究旨在探讨口服类固醇对伴有鼻息肉的慢性鼻-鼻窦炎(CRSwNP)患者嗅觉障碍的影响。
这是一项前瞻性随机非盲研究。选择有嗅觉减退的 CRSwNP 患者(n=140)分为两组;A 组接受 7 天的口服类固醇治疗,同时接受 12 周的鼻内类固醇和鼻腔冲洗治疗;B 组接受 12 周的鼻内类固醇和鼻腔冲洗治疗。评估包括 Sniffin' Sticks 评分、嗅觉和不适的视觉模拟评分(VASsmell、VASdis)、鼻-鼻窦结局测试-22(SNOT22-Gr)和内镜表现(EAS)。
主要目标是比较 A 组和 B 组不同治疗方法在 2、12 和 24 周时的嗅觉效果。次要目标包括比较两组之间的 EAS、VASdis 和 SNOT22-Gr,评估治疗效果的持续时间,以及研究评估参数之间的潜在相关性。
在所有参数中,除了 VASdis 外,2 周评估均显示出显著的统计学差异(P<0.001)。在 24 周评估时,A 组的嗅觉结果(Sniffin' Sticks 和 VASsmell 评分)明显更好(P<0.001)。在组内,12 周和 24 周评估之间的治疗效果保持稳定(P>0.05)。在 12 周评估时,Sniffin' Sticks 评分与 EAS 呈强相关(rho=0.58,P<0.001)。
我们的结果表明,在经过精心选择的 CRSwNP 患者中,口服和鼻内类固醇联合治疗可能会导致早期嗅觉恢复,并可能产生长期效果。